Anti-IL5 mepolizumab minimally influences residual blood eosinophils in severe asthma:

Glenn Van Hulst, Joseph Jorssen, Nathalie Jacobs, Monique Henket, Renaud Louis, Florence Schleich, Fabrice Bureau, and Christophe J. Desmet

17 March, 2022

NZ Respiratory Research Review Issue 200

Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis:

Davies Adeloye, PhD, Peige Song, PhD, Yajie Zhu, PhD, Prof Harry Campbell, MD, Prof Aziz Sheikh, MD Prof Igor Rudan, PhD et al.

10 March, 2022

NZ Respiratory Research Review Issue 198

Early Bactericidal Activity of Meropenem plus Clavulanate (with or without Rifampin) for Tuberculosis: The COMRADE Randomized, Phase 2A Clinical Trial:

Veronique De Jager, Nikhil Gupte, Silvia Nunes, Grace L. Barnes, Rob Christiaan van Wijk, Joni Mostert, Susan E. Dorman, Ahmed A. Abulfathi, Caryn M. Upton, Alan Faraj, Eric L. Nuermberger, Gyanu Lamichhane, Elin M. Svensson, Ulrika S. H. Simonsson, Andreas H. Diacon, Kelly E. Dooley, and the COMRADE Study Team

8 March, 2022

NZ Respiratory Research Review Issue 199

The effectiveness of pulmonary rehabilitation for Post-COVID symptoms: A rapid review of the literature:

Lesley J.J. Soril a,b , Ronald W. Damant a,c , Grace Y. Lam c , Maeve P. Smith c , Jason Weatherald d , Jean Bourbeau e , Paul Hernandez f , Michael K. Stickland

1 March, 2022

NZ Respiratory Research Review Issue 196

Multinight Prevalence, Variability, and Diagnostic Misclassification of Obstructive Sleep Apnea:

Bastien Lechat, Ganesh Naik, Amy Reynolds, Atqiya Aishah, Hannah Scott, Kelly A. Loffler, Andrew Vakulin, Pierre Escourrou, R. Doug McEvoy, Robert J. Adams, Peter G. Catcheside, and Danny J. Eckert

1 March, 2022

NZ Respiratory Research Review Issue 197

Azithromycin for Poorly Controlled Asthma in Children - A Randomized Controlled Trial:

Jagat Jeevan Ghimire, MD Kana Ram Jat, MD Jhuma Sankar, MD Rakesh Lodha, MD Venkat K. Iyer, MD Hitender Gautam, MD Seema Sood, MD S.K. Kabra, MD

21 February, 2022

NZ Respiratory Research Review Issue 200

Benralizumab Effectiveness in Severe Asthma Is Independent of Previous Biologic Use:

David J. Jackson, MRCP, PhD Hassan Burhan, MD Andrew Menzies-Gow, PhD Paul Pfeffer, PhD Alexandra Nanzer, PhD Esther Garcia Gil, MD Tamsin Morris, BSc Trung N. Tran, MD, PhD Ian Hirsch, PhD Sabada Dube, PhD

21 February, 2022

NZ Respiratory Research Review Issue 200

Association between very to moderate preterm births, lung function deficits, and COPD at age 53 years: analysis of a prospective cohort study:

Dinh S Bui, PhD, Jennifer L Perret, PhD, Prof E Haydn Walters, DM Caroline J Lodge, PhD Gayan Bowatte, PhD Garun S Hamilton, PhD et al.

18 February, 2022

NZ Respiratory Research Review Issue 198

An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study):

Aliasgar Esmail, Suzette Oelofse, Carl Lombard, Rubeshan Perumal, Linda Mbuthini, Akhter Goolam Mahomed, Ebrahim Variava, John Black, Patrick Oluboyo, Nelile Gwentshu, Eric Ngam, Tertius Ackerman, Linde Marais, Lynelle Mottay, Stuart Meier, Anil Pooran, Michele Tomasicchio, Julian Te Riele, Brigitta Derendinger, Norbert Ndjeka, Gary Maartens, Robin Warren, Neil Martinson, and Keertan Dheda

17 February, 2022

NZ Respiratory Research Review Issue 199

Identifying Higher-Volume Antibiotic Outpatient Prescribers Using Publicly Available Medicare Part D Data — United States, 2019:

Katryna A. Gouin, MPH; Katherine E. Fleming-Dutra, MD; Sharon Tsay, MD; Destani Bizune, MPH; Lauri A. Hicks, DO; Sarah Kabbani, MD

11 February, 2022

NZ Respiratory Research Review Issue 196